A GWAS of 12,518 prostate cancer cases identified rs78943174 within the NAALADL2 locus as one of two loci associated with a high Gleason sum score,22 leading to suggestions that NAALADL2 could be a potentially valuable therapeutic target21. The gene discussed is NAALADL2; the disease is prostate cancer.